Bajaj Healthcare · NSE: BAJAJHCARE · BSE: 539872
Q2 FY23 results · Jul–Sep 2022
Bajaj Healthcare reported revenue from operations of ₹200.89 crore (up 33.1% from Q2 FY22) and net profit of ₹16.36 crore (down 5.2% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a standalone basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 200.89 | 150.91 | +33.1% | 172.07 | +16.8% |
| Other income | 0.13 | 0.12 | +11.1% | 0.67 | −80.4% |
| Total income | 201.03 | 151.03 | +33.1% | 172.74 | +16.4% |
| Profit before tax | 22.02 | 22.18 | −0.7% | 16.16 | +36.3% |
| Net profit for the period | 16.36 | 17.25 | −5.2% | 12.02 | +36.1% |
| EPS, basic (₹) | 5.93 | 6.25 | −5.1% | 4.35 | +36.3% |
| Net margin (%) | 8.1 | 11.4 | 7.0 |
Standalone
- Filed with BSE
- 23 Nov 2022, 17:34 IST
- Board meeting
- 11 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE